The epidemiology of blood pressure in very old age has not been thoroughly studied. The objective of this study was to study blood pressure changes throughout old age and changes in blood pressure and antihypertensive drug use from 1981 to 2005. The study includes 1133 blood pressure measurements from two studies carried out in Umeå, Sweden. The U70 study (1981)(1982)(1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990) included individuals aged 70-88 and the Umeå 85 þ /GERDA study (2000)(2001)(2002)(2003)(2004)(2005) covered people aged 85, 90 or X95 years. The impact of age, sex and year of investigation on blood pressure was investigated using linear regression. Mean diastolic blood pressure (DBP) decreased by 0.35 mm Hg (Po0.001) for each year of age. An inverted U-shaped relation was found between age and systolic blood pressure (SBP), with SBP reaching its maximum at 74.5 years. Mean SBP and DBP also decreased over time (SBP by 0.44 mm Hg per year, Po0.001 and DBP by 0.34 mm Hg per year, Po0.001). The proportion of participants on antihypertensive drugs increased from 39.0% in 1981 to 69.4% in 2005. In this study of people aged X70 years, mean SBP and DBP decreased with higher age and later investigation year. Antihypertensive drug use increased with time, which might partly explain the observed cohort effect.
INTRODUCTION
Hypertension is an established risk factor for the development of atherosclerosis and for cardiovascular disorders such as myocardial infarction, heart failure and stroke. Blood pressure measurement is also one of the most commonly performed clinical investigations, but in order to interpret blood pressure values an understanding of the epidemiology of blood pressure and the establishment of correct guidelines for the treatment of hypertension are vital. At present, there is limited knowledge regarding these issues in very old people, aged 80 and over. Epidemiological studies have demonstrated that mean blood pressure rises with age, but only up to a certain point. Diastolic blood pressure (DBP) has been shown to decrease in old age whereas systolic blood pressure (SBP) continues to increase. [1] [2] [3] [4] [5] [6] Both phenomena are fundamentally caused by arterial stiffening 7 and lead to an increasing prevalence of isolated systolic hypertension and an increasing pulse pressure (PP). However, most of these studies have not included very old individuals and it has been shown that even SBP declines in very advanced age. [8] [9] [10] The exact cause of this decline and the age span at which it could be expected remain to be fully determined.
The importance of studying blood pressure changes among very old individuals is further supported by indications of paradoxical associations between low blood pressure and increased mortality 11, 12 and dementia 13 in these individuals. These findings could to some extent be explained by underlying disorders such as heart failure, that are coupled to low systolic function and low blood pressure and also to an increased mortality, but it cannot be ruled out that low blood pressure in itself might have an effect.
The prevalence of hypertension increases with age and so, consequently, does the prevalence of antihypertensive treatment. Since knowledge about the detrimental effects of hypertension has become widespread, treatment with antihypertensive drugs has become increasingly common even in higher ages. New types of drugs, such as those that interfere with the renin-angiotensinaldosterone system, have also become generally available in recent years. This increase in treatment with antihypertensive drugs might have led to an overestimation of the age-related drop in mean blood pressure in previous cohort studies.
The aim of the present study was to study changes in blood pressure with age in old and very old people and to investigate how mean blood pressure and antihypertensive drug use has changed over the years from 1981 to 2005.
METHODS Participants
This report is based on data from two epidemiological cohort studies, the U70 study and the Umeå 85 þ /GERDA (GErontological Regional DAtabase) study, both carried out in the municipality of Umeå in northern Sweden. These studies were combined to obtain an age span large enough to investigate the effect of age on blood pressure, while also stuyding cohort effects by covering a time period of approximately two decades. An overview of the data collections is shown in Figure 1 .
The Umeå Longitudinal study (U70), carried out between 1981 and 1990, was designed to resemble the H70 study performed in Gothenburg, Sweden 14 and its purpose was to study medical and social conditions among older people in northern Sweden. The first data collection in the U70 study included a representative sample of people aged 70, 75 and 79 years. However, the 75-year-old cohort was dropped for the next round in 1984 and instead all people aged 82 years and living in the municipality were included (that is, an expansion of the original 79-year-old cohort). Further follow-ups were performed in 1987 and in 1990, meaning the oldest participants were 88 years old in the last data collection. In 1990, a new group of 70-year-olds was also included.
In the Umeå 85 þ /GERDA study, half of all 85-year-olds, all 90-year-olds and all X95-year-olds (range 95-103 years) were eligible for participation and the purpose of the study was to investigate the general health and prerequisites for good aging in very old individuals. Two data collections were performed, in 2000 and in 2005. The investigation in 2005 included both survivors from the first data collection and new individuals from the same age groups. In both studies, participants were selected from population records and age groups were defined based on year of birth. In the U70 study, all subsamples were stratified according to sex and sorted according to date of birth, and a similar number of men and women were then systematically selected. In the Umeå 85 þ /GERDA study, every other 85-year-old from lists sorted according to date of birth, and all 90-year-olds and X95-years-olds were included. In both studies nonresponders from the preceding data collections were eligible for participation in subsequent rounds. An overview of the samples is given in Table 1 .
Some individuals were eligible for participation in more than one data collection, but each occasion will be considered as a separate case. There were 699 eligible cases in the Umeå 85 þ /GERDA study and 840 in the U70 study. The number of dropouts (that is, missing cases owing to declined participation or missing data) was 218 (31.2%) in the Umeå 85 þ /GERDA study and 150 (17.9%) in the U70 study (Po0.001). There was no age difference between the dropouts and the remaining cases in either of the two studies but in the U70 study dropouts were more likely to be women (P ¼ 0.004). The remaining U70 material included a total of 690 cases, representing 341 unique individuals of whom 163 were investigated twice or more. Correspondingly, 397 unique individuals participated in the Umeå 85 þ /GERDA study and 84 of these were investigated twice, resulting in 481 cases. This rendered a total of 1171 cases but blood pressure could not be measured in 38 of these and consequently, the present study is based on 1133 blood pressure measurements, from 705 unique individuals. 
Procedures
All eligible individuals were contacted first by letter and then by telephone and were asked to give their informed consent. In cases where there was severe cognitive impairment the next of kin were also contacted. Participation could be discontinued at any point without a stated reason and without detriment. In the U70 study, investigations were carried out at a geriatric centre, lasted one day and included: a medical interview concerning symptoms, disorders and pharmacological drug use; a social interview; a review of medical records; the taking of blood samples and an electrocardiogram; a physical and dental examination; a psychometric interview, including the MMSE 15 (except in 1981); anthropometric measurements and an assessment of dietary intake by a dietician. The MMSE is a global cognitive measure with a score that ranges from 0-30 points, higher scores indicate better cognitive performance. Home visits were made to some people who could not or were unwilling to come to the geriatric centre.
In the Umeå 85 þ /GERDA study, all investigations were performed during home visits. A comprehensive structured interview was administered, which included questions regarding, for example, life history, living conditions and health status and several assessment scales, such as the MMSE, the Geriatric Depression Scale-15, 16 the Philadelphia Geriatric Centre Morale Scale 17 and the Barthel Activities of Daily Living Index, 18 of which only the MMSE is used in the present study. Some anthropometric data were also collected and medical records were investigated. Interviews with relatives and caregivers were also performed, when applicable.
In both studies, blood pressure was measured once in a supine position after 5 min of rest using a stethoscope, cuff and a mercury manometer or sphygmomanometer. Trained investigators performed the measurements. SBP and DBP were noted at Korotkoff phases I and V, respectively. PP was calculated as SBP-DBP. Pulse frequency was counted by palpation of the radial artery with the subject lying down. Weight and height were used to calculate body mass index (BMI, kg m À 2
). Information about pharmacological drug use was provided by the participants and later crosschecked in medical records. Pharmacological drugs were classified according to the Anatomical Therapeutical Chemical (ATC) Classification System. 19 Drugs belonging to ATC classes C02 (antihypertensives), C03 (diuretics), C07 (beta-blocking agents), C08 (calcium-channel blockers) and C09 (agents acting on the reninangiotensin system) were considered to be antihypertensive drugs. Diuretics were further classified into thiazides (including all low-ceiling diuretics, C03A þ B), loop (high-ceiling diuretics, C03C) and potassiumsparing (C03D). Combination drugs were entered into each of the corresponding classes. Loop diuretics are not primarily used for treating hypertension but were included in the present analyses because of their blood pressure-lowering effect. Each drug was coded as used or not used Figure 1 . Illustration of the sample according to study and year of investigation. Numbers within boxes represent age. Arrows depict cohort samples. 
Statistics
A multiple linear regression model was constructed to estimate the individual effects of age, sex, BMI and year of investigation on SBP, DBP and PP. A similar model was also applied with number of antihypertensive drugs as dependent variable. Curvilinear (quadratic) associations between age and blood pressure were controlled for by including age squared in the models. Longitudinal blood pressure change was investigated in those individuals who participated in two or more examinations. The blood pressure value from the first and last examination (time interval 3-9 years) for each person were compared using paired-samples t-tests. Absolute blood pressure change was investigated in linear regression models adjusted for age, sex, follow-up time and baseline SBP, DBP and PP, respectively. P-values o0.05 were considered significant. The Statistical Package for Social Sciences (SPSS) version 13 and Predictive Analytics Software (PASW) Statistics version 17 (SPSS Inc., Chicago, IL, USA) and SYSTAT 5.2 (Systat Software Inc., Chicago, IL, USA) for Mac were used for data handling and calculations.
RESULTS

Cross-sectional results
An overview of the samples and mean blood pressure in the different years is presented in Table 1 . Mean SBP and DBP were 167.0 and 87.6 mm Hg in 1981 and 142.9 and 71.7 mm Hg in 2005. Figure 2 illustrates mean SBP and DBP in the different samples and at different ages. A trend for blood pressure to decrease with higher ages can be seen, as well as the presence of higher blood pressure in earlier samples.
To investigate the relative impact of age, sex and year of investigation on blood pressure, multiple linear regressions were performed ( Table 2 ). The models were also adjusted for BMI, and the age squared was included to check for curvilinear relationships, which were found for SBP and PP, but not for DBP (P ¼ 0.90 for squared variable).
Mean DBP decreased by 0.35 mm Hg for each year of increasing age (Po0.001). The age at which SBP and PP reached their maximum values was calculated from the second-degree functions and was found to be 74.5 years for SBP and 80.6 years for PP. On the basis of the second-degree equation, the expected absolute decline in SBP from 75 to 80 years of age was 0.93 mm Hg, from 80 to 85 years 2.5 mm Hg, from 85 to 90 years 4.1 mm Hg and from 90 to 95 years 5.6 mm Hg.
Regarding time trends and sex differences, mean SBP decreased by 0.44 mm Hg (Po0.001) for each subsequent year, and women had higher mean SBP than men (6.30 mm Hg higher, Po0.001). DBP decreased by 0.34 mm Hg (Po0.001) for each year, but no sex difference was detected (P ¼ 0.80). PP was higher among women than among men (5.92 mm Hg higher, Po0.001) but had no significant relation to year of investigation.
BMI was positively associated with SBP and DBP, but not PP (Table 2 ). In similar multiple linear regression analyses, pulse frequency was related only to the year of investigation (for each year the mean frequency was 0.44 beat min À 1 lower, Po0.001).
Longitudinal results A total of 247 individuals participated in more than one examination and thus provided data on longitudinal blood pressure change. Mean SBP (160.8 vs 147.3 mm Hg, Po0.001), DBP (82.3 vs 76.5 mm Hg, Po0.001) and PP (78.7 vs 70.9 mm Hg, Po0.001) were significantly lower at the follow-up examination, as can also be seen in Figure 2 . SBP declined in 64.8%, DBP in 58.3% and PP in 56.3% of the participants (by X5 mm Hg). Absolute blood pressure change was investigated in linear regression models adjusted for age, sex, follow-up time (range 3-9 years) and baseline SBP, DBP and PP, respectively. These models are presented in Table 3 . Baseline blood pressure was a strong predictor for blood pressure decline and higher age and male sex led to a predisposition to greater declines in SBP and PP, but not in DBP. The prevalence of treatment with any antihypertensive drug was 40.5% at baseline and 52.6% at follow-up. Mean number of antihypertensive drugs received at baseline was 0.59 and at follow-up 0.88.
Antihypertensive medication
Pharmacological drug use is presented in 
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In a multiple linear regression model including age, sex and investigation year as independent variables, it was found that for each calendar year, the mean number of antihypertensive drugs received per individual increased by 0.034 (95% CI 0.025-0.043, Po0.001). Age had no significant effect on antihypertensive drug use (P ¼ 0.09), but women received 0.2 more antihypertensive drugs than men (95% CI 0.084-0.317, Po0.001).
DISCUSSION
In the present study, blood pressure declined with age in both cross-sectional and longitudinal analyses of a sample comprising individuals aged 70-103 years. Blood pressure also declined over time from 1981 to 2005. During this period, both the prevalence of treatment with antihypertensive drugs and the number of such drugs taken per person increased.
The present findings agree with previous reports of blood pressure decline in old age. Some have shown that only DBP decreases, whereas SBP continually increases, 1, 3, 6 but others have demonstrated an age-related fall in SBP. 8, 9, 20, 21 Most of the former studies did not include very old participants and it seems that SBP starts decreasing with more advanced age. In the current study, SBP and PP exhibited curvilinear relationships with age and increased until 74.5 and 80.6 years of age, respectively, then decreased, whereas DBP decreased linearly, implying that DBP reaches its peak value at a younger age. It is, however, likely that the age when blood pressure starts declining varies widely among individuals and age itself should probably be regarded mainly as a marker of some underlying pathology that affects blood pressure levels. The mechanism behind the observed age-related decrease in blood pressure is, however, unclear. The continuous increase in SBP and eventual decrease in DBP observed in previous studies can both be attributed to arterial stiffening. 7 However, reduction in arterial stiffness is not a likely explanation for the SBP decline observed in the present study as this condition is, in essence, irreversible, although it can be affected by antihypertensive treatment. 22 A long life with increasing arterial stiffness, in many cases augmented by hypertension, also increases the risk of developing left ventricular hypertrophy and subsequent congestive heart failure, 23 which might lead to blood pressure decline. In the Leiden 85-plus study, low SBP was found to correlate with cardiac dysfunction. 24 A potentially increasing prevalence of antihypertensive treatment with age could also influence blood pressure levels, but this could not be demonstrated in the present study. A higher BMI was associated with higher SBP and DBP in the present study, indicting that poorer nutritional status or low body weight might predispose an individual to a decline in blood pressure, as also suggested by others. 20 Diseases such as dementia may also lead to a lower blood pressure [25] [26] [27] and a survival bias due to increased mortality in individuals with hypertension could contribute. Several studies have, however, shown that lower, rather than high, blood pressure is associated with an increased mortality rate in the very old. 11, 12, 28 Moreover, selective mortality might affect cross-sectional results, but does not explain why blood pressure also declined in the longitudinal analysis.
As illustrated in the present results, blood pressure decline should probably not be expected in all individuals, probably due to differences in underlying characteristics, such as diseases. This was not investigated in the present study due to possible differences in diagnostic criteria in the U70 and Umeå 85 þ / GERDA studies. In a sample of healthy individuals without diseases or medications that could affect blood pressure, 29 SBP and DBP increased from middle age and reached a plateau, without declining, in older women, but continued to increase in men. However, the number of individuals aged 80 years or older was limited. 29 A decline in blood pressure was not only associated with age, but also with time, suggesting cohort effects on blood pressure. The prevalence of treatment with antihypertensive drugs increased with time, which could partly explain the effect. In another study performed during the 1980s, a similar decline in mean blood pressure was demonstrated and was only partly explained by an increasing prevalence of antihypertensive treatment. 21 Cohort effects on blood pressure decline were suggested in a prospective American study started in 1975 5 and in a Danish study performed between 1964 and 1991, where the prevalence of antihypertensive treatment also increased over the years. 30 In the latter study, there was an increase in the number of untreated normotensives, implying that treatment was not the sole cause of the blood pressure decline. Indeed, there are other possible explanations for the decline in mean blood pressure over the years. Improved treatment of conditions that can lower blood pressure has led to better survival in those affected and possibly increased the proportion of individuals with low blood pressure. Changes in body composition might influence blood pressure levels but there was little variation in BMI over the years in the present study (Table 1) and adjustment for BMI in the regression models did not cancel out the effect of investigation year. Changes in dietary standards over the years could also affect blood pressure levels and there could also be more long-term explanations such as differences in the environment, nutritional status and healthpromoting behaviour during younger age, but this is difficult to evaluate.
In this study, women had higher blood pressure (SBP and PP) than men, which has previously been demonstrated in older populations. 1, 3, 5 It seems that men have higher blood pressure in younger age but in older age the association is reversed 1, 3 or the difference narrowed. 6, 29 Possible explanations could be that many men with high blood pressure die before reaching very old age or that hypertension is treated more vigorously in men. In the current study, however, women received more antihypertensive drugs. It has also been postulated that women might experience an accelerated rise in blood pressure in relation to menopause. 31 Male sex was a strong predictor of blood pressure decline in the longitudinal analysis, which could be due to sex differences in underlying factors such as cardiac function or other morbidities.
Baseline blood pressure was also a strong determinant for the magnitude of the blood pressure decline.
Limitations and strengths One weakness of this study is the combination of data from two different studies, with possible methodological and demographical dissimilarities. However, the studies were performed in the same municipality and the investigation procedure was similar regarding the main variables blood pressure and pharmacological drug use, except that blood pressure was measured in a hospital environment in the U70 study and in the participants' homes in the Umeå 85 þ /GERDA study. Consequently, a white coat effect 32 could have led to higher blood pressure values in the U70 study. The white coat effect is not, however, universal and should only affect part of the research sample. The ages of participants varied between data collections, although there was some age overlap between the two studies. Adjusting for age and year of investigation in multiple regression models might not fully compensate for this. Further, a time span of ten years (1990-2000) is not represented, which disrupts the continuity of the study but it is difficult to evaluate whether this could have affected the results.
Another important limitation is that due to the observational nature of the data, it was not possible to separate the effect of an increased use of antihypertensive drugs from other possible cohort effects. There are strong selection effects making it impossible to include antihypertensive drugs in the regression analyses as people that develop hypertension over the years are, naturally, also at increased risk of being started on antihypertensive drugs. Therefore, any real blood pressure lowering effect would have been obscured by the bias towards higher blood pressure in the group of people treated with antihypertensive drugs. Cardiovascular and other comorbidities could not be included in the analyses due to possible differences in diagnostic criteria and procedure between the two studies, which made it impossible to estimate their contribution to the cohort effect. These limitations should be taken into account when interpreting the results. To what extent the increased use of antihypertensive drugs has contributed to the decreased blood pressure over the years cannot reliably be established from the present study. Blood pressure was measured in the supine position, which has been shown to result in higher values than measurements performed with the subject seated. 33, 34 This effect is more prominent in old age, particularly, according to some, in those aged 80 years and older. 33 This should be remembered when evaluating absolute blood pressure values from the present study but should not influence the directions of the observed associations. As a consequence of the supine blood pressure measurement, orthostatic reactions could not be detected. Information about treatment indications and doses was unavailable and drugs considered antihypertensive could have been prescribed on other indications. However, regardless of the reason for treatment, these drugs can still be considered blood pressure lowering.
This study also has several strengths. It covers a substantial time period, enabling study of time-related changes, and includes a large age span. Both cross-sectional and longitudinal effects could be studied. Although blood pressure was measured only once, the measurements were of good quality and uniform across investigators and data collections. Data on drug treatment were also carefully collected and are reliable. Finally, the sample used is representative of the population as the dropout rate was relatively small.
CONCLUSION
In these analyses of two population-based studies of old and very old people spanning the years 1981 to 2005, decreasing mean blood pressure was found for higher age in both cross-sectional and longitudinal analyses. Blood pressure also decreased with later investigation year, indicating a cohort effect. The use of antihypertensive drugs increased with time, but was not related to increasing age, and might be one reason for the cohort effect. Future research should focus on identifying underlying reasons for the observed blood pressure decline in advanced age.
What is known about this topic
Blood pressure (BP) increases with age, but diastolic BP decreases after midlife. Some have indicated that systolic BP also decreases in high age. There are indications of a reduction in mean BP over the last decades.
What this study adds Covering a wide age range, this study confirms that both systolic and diastolic BP decrease in high age. Systolic BP seems to decrease first in very high age, which explains why this trend is not evident in studies of younger populations. Mean blood pressure in the studied population decreased from 1981 to 2005, which supports the presence of cohort effects on blood pressure. Cohort effects could partly be explained by an increasing prevalence of antihypertensive treatment.
